- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Day 2 Recap: Maui Derm NP+PA Fall 2024
Author(s):
Catch up on coverage from the second day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee.
Image Credit: © Dermatology Times
To stay informed with the latest conference insights, subscribe to receive our E-newsletters.
Infectious Disease and Dermatology Crossover: What Providers Need to Know
At Maui Derm NP+PA Fall 2024, Ted Rosen, MD, and George Hightower, MD, PhD, review the landscape of infectious diseases that can have dermatologic involvement, including viral, bacterial, fungal, and parasitic illnesses.
Importance of APPs in Treating and Understanding AD
Researchers analyzed APPs treatment and perceptions on AD in studies focusing on patient satisfaction and patients with skin of color.
Raj Chovatiya, MD, PhD: Hidradenitis Suppurativa Is the ‘Definition of Unmet Need’
This Maui Derm NP+PA Fall session discusses the latest advancements in hidradenitis suppurativa treatment, the evolving therapeutic landscape, and the critical need for timely diagnosis and aggressive care.
Jason Hawkes, MD: Urticaria Characteristics, Patient Concerns, and Therapies
Researchers analyzed APPs treatment and perceptions on AD in studies focusing on patient satisfaction and patients with skin of color.
To view all conference coverage from Maui Derm NP+PA Fall, click here.
